Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:30 AM
Study NCT ID:
NCT01105702
Status:
TERMINATED
Last Update Posted:
2016-08-04
First Post:
2010-04-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-12
First Submit QC Date:
None
Study First Post Date:
2010-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-05
Results First Submit QC Date:
None
Results First Post Date:
2015-11-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-07-06
Last Update Post Date:
2016-08-04
Last Update Post Date Type:
ESTIMATED